Cancer Prevention News and Research

RSS

Testing for high-risk types of HPV DNA can be effective in preventing invasive cervical cancer

Results from a study of more than 90,000 Italian women published by the Lancet Oncology found that testing for high-risk types of the human papillomavirus (HPV) DNA is significantly more effective in preventing invasive cervical cancer than cytology (Pap testing) alone.

19 Jan 2010

Study results show increase of mortality due to colon cancer in Spain

There are stark geographical contrasts in the incidence of colon cancer worldwide. The new study analyses the causes of these disparities, starting with Spanish trends between 1951 and 2006 in terms of certain changes in consumption (tobacco, alcohol, red and processed meat, fish, vegetables...) and also behaviour (physical exercise, sedentary lifestyles-).

18 Jan 2010

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

Thanks in part to more than a decade of preclinical work by Dartmouth researchers, a Japanese biopharmaceutical firm is preparing to develop and market throughout Asia a drug for the treatment of chronic kidney disease (CKD).

18 Jan 2010

CAN DO Houston expands childhood obesity initiative with major grant

CAN DO Houston (Children and Neighbors Defeating Obesity) will expand its community-based efforts with a $360,000 grant from the Robert Wood Johnson Foundation's "Healthy Kids, Healthy Communities" initiative.

13 Jan 2010

Canadian Cancer Society calls on the B.C. government to ban cosmetic use of pesticides

The Canadian Cancer Society British Columbia and Yukon today called on the B.C. government to enact legislation to ban the cosmetic use of pesticides that would set a new national standard. The Society is also asking British Columbians to participate in the on-line public consultation.

8 Jan 2010

Study suggests pomegranates may prevent growth of breast cancer cells

US scientists have carried out a series of laboratory tests suggesting that natural compounds in pomegranates may prevent the growth of breast cancer cells.

7 Jan 2010

Anti-aromatase phytochemicals in pomegranates reduce hormone-dependent breast cancer

Eating fruit, such as pomegranates, that contain anti-aromatase phytochemicals reduces the incidence of hormone-dependent breast cancer, according to results of a study published in the January issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.

5 Jan 2010

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine.

5 Jan 2010

New chemoprevention therapy for skin cancer

People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.

5 Jan 2010

Chlorophyll and chlorophyllin effective in limiting aflatoxin absorption in humans

A new study has found that chlorophyll and its derivative chlorophyllin are effective in limiting the absorption of aflatoxin in humans. Aflatoxin is produced by a fungus that is a contaminant of grains including corn, peanuts and soybeans; it is known to cause liver cancer - and can work in concert with other health concerns, such as hepatitis.

30 Dec 2009

Olive oil for prevention of breast cancer

Ana Ripoll, Rector of Universitat Aut-noma de Barcelona (UAB), and Pedro Barato, President of "Organizaci-n Interprofesional del Aceite de Oliva Espa-ol", signed a research agreement to carry out an in depth study on how the intake of olive oil can work towards preventing and fighting against breast cancer.

22 Dec 2009

CPRIT extends Company Investment application date to January 12, 2010

The Cancer Prevention and Research Institute of Texas (CPRIT) announced today that it has extended the deadline to January 12, 2010 to file a letter of intent to submit a proposal for the Company Investment request for application (RFA). The RFA is available on the CPRIT website, www.cprit.state.tx.us/funding.html.

22 Dec 2009

UAB professors honored for scientific contributions and outstanding mentorship

Three University of Alabama at Birmingham (UAB) professors have been elected fellows of the American Association for the Advancement of Science (AAAS).

18 Dec 2009

Study findings highlight the need to develop specific health policies to address social disparities

Racial and ethnic disparities in cancer survival are greatest for cancers that can be detected early and treated successfully, including breast and prostate cancer, according to a study by researchers at Columbia University's Mailman School of Public Health and Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center/NewYork-Presbyterian Hospital.

18 Dec 2009

Phase Forward’s InForm Global Trial Management solution standardized to support early-stage clinical trials

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK’s Drug Development Office – the drug development arm of the world’s largest independent organization dedicated to cancer research – is standardizing on Phase Forward’s InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.

17 Dec 2009

SOCS1 molecule prevents cancer-causing activity of cytokines, discover researchers

Canadian researchers have discovered a novel molecular mechanism that prevents cancer. In the December 11 edition of the prestigious journal Molecular Cell, scientists from the Universit- de Montr-al and the Universit- de Sherbrooke explain how they found that the SOCS1 molecule prevents the cancer-causing activity of cytokines, hormones that are culprits in cancer-prone chronic inflammation diseases such as Crohns, in smokers and people exposed to asbestos.

12 Dec 2009

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggests that these agents may play a role in reducing recurrent breast cancer as well.

11 Dec 2009

Enzo Biochem and Ikonisys sign agreement to market molecular-based cervical cancer test

Enzo Biochem, Inc. announced today that its Enzo Clinical Lab division has entered into an exclusive marketing partnership covering the States of New York and New Jersey with privately-owned Ikonisys, Inc., of New Haven, CT, relating to Ikonisys’ proprietary oncoFISH® cervical test, a laboratory developed test for cervical cancer prevention.

10 Dec 2009

CPRIT awards $2 million grant to study prostate cancer

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded its initial grant for a First-Time, Tenure Track Faculty Member to the University of Texas Southwestern Medical Center in Dallas.

10 Dec 2009

Genetic variations in Sonic Hedgehog pathway associated with response to standard immunotherapy

Genetic variations in the Sonic Hedgehog pathway increase the likelihood of recurrence, reduce survival time and limit response to therapy for people with non-muscle invasive bladder cancer, scientists from The University of Texas M. D. Anderson Cancer Center reported today at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.

10 Dec 2009

Cancer Prevention News and Research

Testing for high-risk types of HPV DNA can be effective in preventing invasive cervical cancer

Study results show increase of mortality due to colon cancer in Spain

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

CAN DO Houston expands childhood obesity initiative with major grant

Canadian Cancer Society calls on the B.C. government to ban cosmetic use of pesticides

Study suggests pomegranates may prevent growth of breast cancer cells

Anti-aromatase phytochemicals in pomegranates reduce hormone-dependent breast cancer

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

New chemoprevention therapy for skin cancer

Chlorophyll and chlorophyllin effective in limiting aflatoxin absorption in humans

Olive oil for prevention of breast cancer

CPRIT extends Company Investment application date to January 12, 2010

UAB professors honored for scientific contributions and outstanding mentorship

Study findings highlight the need to develop specific health policies to address social disparities

Phase Forward’s InForm Global Trial Management solution standardized to support early-stage clinical trials

SOCS1 molecule prevents cancer-causing activity of cytokines, discover researchers

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Enzo Biochem and Ikonisys sign agreement to market molecular-based cervical cancer test

CPRIT awards $2 million grant to study prostate cancer

Genetic variations in Sonic Hedgehog pathway associated with response to standard immunotherapy

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News